Home

ROBERT N WILSON

CIK 1189022 · last filed 2026-06-29

ROBERT N WILSON is a corporate insider who has filed 69 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider was granted $950.0K of CALC on Jun 29, 2026. Across all open-market trades the lifetime net is +$2.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $21.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$21.77M

Companies

7

Total Filings

69

Lifetime Open-Market Net

$2.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CALC Director 1,604,650 $0.72 $1.15M $222.4K 9 2026-06-29
CalciMedica, Inc. (SCPH) Delisted Director 417,529 $5.67 $2.37M $400.8K 3 2024-11-01
CalciMedica, Inc. (GRAY) Delisted Director 181,655 $5.50 $999.1K $0 1 2023-03-22
SCHW Director 194,582 $105.97 $20.62M $0 25 2018-12-14
HESS CORP (HES) Delisted Director 79,581 $160.40 $12.76M $475.0K 13 2016-03-03
MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted Director 760,936 — — $1.83M 16 2015-07-06
VIVUS INC (VVUS) Delisted Director 2,565 — — $0 2 2013-08-16

Recent Filings

69 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 CALC Grant (A) +1,182,621 $950.0K EDGAR
2025-07-18 CALC Buy (P) +4,500 $12.9K EDGAR
2025-06-26 CALC Grant (A) — $0 EDGAR
2024-11-01 CalciMedica, Inc. (SCPH) Delisted Buy (P) +53,333 $200.0K EDGAR
2024-08-28 CalciMedica, Inc. (SCPH) Delisted Grant (A) — $0 EDGAR
2024-08-26 CalciMedica, Inc. (SCPH) Delisted Buy (P) +54,000 $200.8K EDGAR
2024-07-02 CALC Buy (P) +51,278 $180.5K EDGAR
2024-07-01 CALC Buy (P) +8,443 $27.3K EDGAR
2024-04-22 CALC Grant (A) — $0 EDGAR
2024-01-25 CALC Grant (A) +68,314 $291.5K EDGAR
Showing 1–10 of 69
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.